Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Oil & Gas Virtual Investor Conference Agenda Announced for November 13th
-
Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials
-
Transactions in connection with share buyback programme
-
Fusemachines Welcomes Genese Solution as an Authorized Reseller
-
Form 8.3 - Unite Group Plc
-
WORKSPORT ANNOUNCES FINAL PRICING AND INITIAL MODEL LINEUP FOR SOLIS SOLAR TONNEAU COVER
-
Form 8.3 - Idox Plc
-
American Rare Earths Announces Strong Initial Beneficiation Optimization Results and Updated Preliminary Mineral Processing Flowsheet
-
BioCardia Announces Henry Ford Health Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial
-
Vittoria Biotherapeutics Announces Presentation of First-in-Human Interim Phase1 Data for VIPER-101 at ASH2025
-
Genius Group and Nuanu Complete Agreements, With a Combined Valuation of $14 Million, to Launch Genius School and Genius City, Bali
-
Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility
-
Streamex Corp. (NASDAQ: STEX) Announces Launch of $100,000,000 USD GLDY Pre-Sale – A Gold-Backed Yield Generating Stablecoin Offering Institutional Yield on Physical Gold Bullion
-
HyOrc (HYOR) Enters North American Rail with Hydrogen-Ready Engine MOU; Green Methanol Project Advances Toward Financed Offtake, Signaling Clear Path to Revenue
-
Houston American Energy Corp. Reports Preliminary, Unaudited Results for Third Quarter 2025
-
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
-
Currenc Group Inc. Announces Third Quarter 2025 Unaudited Financial Results
-
WISeKey International Holding AG (Nasdaq: WKEY) and Columbus Acquisition Corp. (Nasdaq: COLA) Execute Business Combination Agreement to Publicly List WISeKey’s Subsidiary WISeSat.Space Corp. Under T
-
Woodward Schedules Fiscal 2025 Fourth Quarter and Full Year Earnings Release and Conference Call
-
NewGen Announces Up to US$2 Million Share Repurchase Program
-
GIFTIFY, INC. REPORTS THIRD QUARTER 2025 RESULTS
-
The Energy Breakthrough That Could Power the AI Era
-
The New Gold Rush of the AI Era
-
Vatica Health earns consistent high performer award
-
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
-
Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Combination with Anti-PD1 Checkpoint Inhib
-
Roper Technologies strengthens AI leadership with key executive appointments
-
Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
-
Rubicon Organics Secures $4 million in Financing to Support Strategic Growth Initiatives
-
HeartCore Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
-
GlobalFoundries Licenses GaN Technology from TSMC to Accelerate U.S.-Manufactured Power Portfolio for Datacenter, Industrial and Automotive Customers
-
VisionWave Unveils the Varan UGV — Leading the Ground Autonomy Revolution
-
FAST TRACK GROUP Completes Three-Part Brand Activation Project
-
Snail, Inc. Sets Third Quarter 2025 Conference Call for Wednesday, November 12, 2025 at 4:30 p.m. ET
-
Form 8.3 - Empiric Student Property Plc
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Atlanticus Reports Third Quarter 2025 Financial Results
-
Enlight Announces $1.44 Billion Debt Financing for Flagship Snowflake A Project in Arizona
-
Somnia Launches Data Streams, Bringing Real-Time Reactivity Onchain
-
Wenlay Hosts Community Fireside Chat, Discusses “Gas Sponsorship” and “Social Recovery” Features
-
Motel 6 and Studio 6 Score With New PLAY Hockey Partnership in Canada
-
The U.S. Department of War Issues New Cybersecurity Regulations — Mobilicom’s Secured Autonomy™ Framework is one of the First-to-Market Solutions Addressing these Regulations for Autonomous Syst
-
Arch Biopartners Arranges Non-Brokered Private Placement
-
Clearmind Medicine Successfully Completed First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
-
Foresight Expands Global Reach Through Strategic Collaboration with Leading Chinese Stereo Solutions Manufacturer
-
Garant Expands Electric Lineup with Powerful Cordless Snow Blowers That Help Save Snowfall Slowdown
-
USX Cyber® Launches Guardient® for SMBs as CMMC Enforcement Begins - Helping Businesses Get Compliant Faster, More Affordably, and More Effectively
-
Quanted launches AI data discovery platform for buy-side front-office and data teams
-
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
-
HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
